Mutual Of America Capital Management LLC Sorrento Therapeutics, Inc. Transaction History

Mutual Of America Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.24 - $2.33 $323,547 - $607,955	-260,925 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$2.0 - $4.9 $22,682 - $55,570	-11,341 Reduced 4.17%	260,925 $608,000
Q4 2021 Feb 03, 2022	SELL	$4.65 - $7.23 $11,815 - $18,371	-2,541 Reduced 0.92%	272,266 $1.27 Million
Q3 2021 Nov 10, 2021	SELL	$7.41 - $10.99 $29,336 - $43,509	-3,959 Reduced 1.42%	274,807 $2.1 Million
Q2 2021 Aug 06, 2021	SELL	$6.35 - $10.0 $76,180 - $119,970	-11,997 Reduced 4.13%	278,766 $2.7 Million
Q1 2021 May 13, 2021	BUY	$7.03 - $16.51 $429,772 - $1.01 Million	61,134 Added 26.62%	290,763 $2.41 Million
Q4 2020 Feb 12, 2021	BUY	$5.76 - $11.95 $203,276 - $421,727	35,291 Added 18.16%	229,629 $1.57 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $517,588 - $1.58 Million	83,888 Added 75.95%	194,338 $2.17 Million
Q2 2020 Aug 06, 2020	BUY	$1.73 - $6.76 $191,078 - $746,642	110,450 New	110,450 $694,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.